6550--629-26-1-042-0000 FISHER IMMUNOSUPPRESSANT (VA-26-00014575)
ID: 36C25626Q0083Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF256-NETWORK CONTRACT OFFICE 16 (36C256)RIDGELAND, MS, 39157, USA

NAICS

Medical Laboratories (621511)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/workspace/contract/opp/97c1652dc0114becaead9d22044e89d5/view
Timeline
    Description

    The Department of Veterans Affairs, through the Network Contracting Office (NCO) 16, intends to award a sole-source contract to Thermofisher Scientific for the provision of Fisher Immunosuppressant clinical products. This procurement aims to supply reagents, kits, and consumables necessary for in vitro diagnostic medical devices that quantitatively determine tacrolimus levels in human whole blood, which is critical for managing kidney and liver allograft patients receiving tacrolimus therapy. The contract is set to run from November 1, 2025, to September 30, 2026, with four optional one-year extensions, and interested parties must submit a capabilities statement by October 27, 2025, at 3:00 PM CST to kimberly.anderson6@va.gov, referencing solicitation number 36C25626Q0083. All interested vendors must be registered with the System for Award Management (SAM) to be eligible for contract award.

    Point(s) of Contact
    KIMBERLY ANDERSONCS
    (337) 591-9873
    KIMBERLY.ANDERSON6@VA.GOV
    Files
    Title
    Posted
    36C25626Q0083_1.docx
    The Department of Veterans Affairs, Network Contracting Office (NCO) 16, intends to award a sole-source contract to Thermofisher Scientific for Fisher Immunosuppressant clinical products. This notice, solicitation number 36C25626Q0083, is an intent to sole source under FAR 6.302-1. The contract will provide reagents, kits, and consumables for in vitro diagnostic medical devices to quantitatively determine tacrolimus in human whole blood, aiding kidney and liver allograft patients at the Southeast Louisiana Veterans Health Care Service. The firm-fixed-price service contract will run from November 1, 2025, to September 30, 2026, with four one-year option periods. Interested parties must submit a capabilities statement by October 27, 2025, at 3:00 PM CST to kimberly.anderson6@va.gov, referencing “Notice of Intent Fisher Immunosuppressant” and solicitation number 36C25626Q0083. Failure to provide convincing evidence of capability may result in NCO 16 negotiating solely with Thermofisher Scientific. All interested parties must be registered with SAM.
    Lifecycle
    Title
    Type
    6550--629-26-1-042-0000 FISHER IMMUNOSUPPRESSANT (VA-26-00014575)
    Currently viewing
    Special Notice
    Similar Opportunities
    Q523--Kidney Organ Perfusion Services
    Buyer not available
    The Department of Veterans Affairs, Network Contracting Office 07, is issuing a presolicitation notice for a sole source contract for Kidney Organ Perfusion Services at the Ralph H. Johnson Department of Veterans Affairs Medical Center (RHJ VA HCS). The contractor will be responsible for receiving organs from a donor Organ Procurement Organization (OPO) and providing perfusion services until the RHJ VA HCS is ready to deliver the organ to the operating room, which must occur within 10 minutes of a mutually agreed-upon time. This service is critical for ensuring the viability of kidney transplants and maintaining the health of veteran patients. Interested parties capable of demonstrating that competition would be advantageous to the government must submit a capabilities statement to Wyona Davis at wyona.davis@va.gov by December 10, 2025, at 3:00 PM Eastern Time, referencing solicitation number 36C247-26-AP-0758.
    J066--Full Service Contract and Software Subscription – BD Synapsys
    Buyer not available
    The Department of Veterans Affairs (VA) intends to award a sole source contract to Becton, Dickinson & Co. (BD Diagnostics Systems) for a full-service contract and annual software subscription for BD Synapsys at the Central Texas Veterans Health Care System. This procurement includes essential services such as a software license, technical support, remote diagnostics, preventative maintenance, and comprehensive repair services, all adhering to OEM specifications and VA standards. The contract is crucial for maintaining the operational efficiency of medical equipment and ensuring high-quality healthcare delivery to veterans. Interested parties must submit their capability statements, including necessary documentation, to Jose Campa at jose.campa@va.gov by 10:00 A.M. CST on December 10, 2025, with the contract expected to be awarded around December 31, 2025.
    J066--NEW – Base Plus 1 Option Yrs – BioMerieux Biofire Service
    Buyer not available
    The Department of Veterans Affairs, Network Contracting Office 17, intends to award a sole source, firm-fixed-price contract to bioMérieux, Inc. for a full-service maintenance agreement covering three Government-owned BioFire FilmArray instruments located at the South Texas Veterans Health Care System. The contract will include a base year and one option year, with services provided exclusively by a BioFire Certified Diagnostic Service Engineer, encompassing all labor, travel, replacement parts, software, and related expenses necessary to maintain the instruments in optimal operating condition and compliance with regulatory requirements. These instruments are critical for laboratory diagnostics, and the government has determined that bioMérieux is the only source capable of providing the required certified service. Interested parties may submit capability statements within seven calendar days of this notice, and for further inquiries, contact Ognian D. Ivanov at 210-694-6302 or via email at ognian.ivanov@va.gov.
    6550--HEMOCHRON SIGNATURE ELITE REAGENTS BASE PLUS 4 OPTION YEARS
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Hemochron Signature Elite Reagents, with a contract that includes a base year and four option years, extending from January 1, 2026, to December 31, 2030. The Southern Arizona VA Health Care System requires these reagents for quality control materials, supplies, and consumables compatible with existing Hemochron Signature Elite Instruments, all of which must be FDA-approved and delivered within specified timeframes. This procurement is critical for maintaining the efficiency and accuracy of patient testing at the Tucson facility. Interested vendors must submit their quotations electronically to Contract Specialist Rebecca Gaba at Rebecca.Gaba@va.gov by December 9, 2025, and are encouraged to address any questions by November 28, 2025.
    6505--Dimethyl Fumarate Capsules
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking offers for the procurement of Dimethyl Fumarate Capsules (120MG and 240MG delayed-release) through solicitation 36E79726R0003. This contract aims to establish a reliable supply source for these pharmaceutical products to support VA, Department of Defense (DoD), Indian Health Service (IHS), and Bureau of Prisons (BOP) facilities, with a contract structure that includes a one-year base ordering period and four one-year options. The products are critical for treating specific medical conditions, and offerors must comply with stringent requirements, including FDA regulations, Drug Supply Chain Security Act (DSCSA) compliance, and the provision of unique National Drug Codes (NDCs). The deadline for submitting offers has been extended to December 9, 2025, at 2:30 PM CST, and interested parties can contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further information.
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to disease diagnosis and patient health assessment. The procurement aims to establish contracts for services that comply with federal, state, and local regulations, including necessary licensing and accreditation, while ensuring that only new items are provided and that grey market goods are strictly prohibited. This opportunity is critical for enhancing the quality of healthcare services provided to veterans, with a focus on compliance with the Trade Agreements Act and other regulatory requirements. Interested vendors should contact Contract Specialist Brian O'Connell at Brian.O'connell@va.gov for further details, and they must adhere to the submission deadlines outlined in the solicitation documents.
    Distribution of CPRR Immunoassays for BioRad BioPlex Lab Tests.
    Buyer not available
    The Department of Veterans Affairs is seeking a contractor to provide the distribution of BioRad BioPlex laboratory reagents for the Seattle VA Medical Center. The procurement aims to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract for automated immunoassay instrumentation capable of performing a variety of diagnostic tests, including those for autoimmune diseases and infectious agents. These reagents and instruments are critical for enhancing laboratory capabilities in diagnosing and managing patient care within the VA system. Interested small businesses must submit their quotes by December 19, 2025, at 17:00 Pacific Time, and can direct inquiries to Hector Gonzalez at hector.gonzalez1@va.gov or by phone at 360-553-7632.
    J065--Bayer Medrad Injectors Full Service
    Buyer not available
    The Department of Veterans Affairs, specifically the Network Contracting Office 17, intends to award a sole source Firm-Fixed-Price Contract to Novamed Corporation for the full service of Bayer Medrad Injectors. This contract, identified as 36C25724P0085, will provide essential services including onsite support by a Bayer certified field engineer, hardware system coverage, calibration, software updates, EPM certified part replacements, and comprehensive inspection and safety testing for various Bayer/Medrad models at the Dallas VA Medical Center. The procurement is being conducted under FAR 13.5, indicating the intent to negotiate with a single source due to the specialized nature of the services required. Interested parties may submit their capability information by December 12, 2025, at 10:00 A.M. CT, to Rafael Rodriguez at Rafael.Rodriguez2@va.gov, as the government may consider competitive procurement based on the responses received.
    6505--Blood Products IDIQ for SFVAHCS
    Buyer not available
    The Department of Veterans Affairs, through Network Contracting Office 23, is seeking proposals for an Indefinite Delivery, Indefinite Quantity (IDIQ) contract for blood products and necessary testing services for the Sioux Falls VA Healthcare System. The contract will cover a base period from February 1, 2026, to September 30, 2026, with five optional ordering periods extending through January 31, 2031, and has a maximum lifetime value of $1,000,000.00, with a guaranteed minimum of $30,000.00. This procurement is critical for ensuring the availability of safe and compliant blood products, adhering to FDA and AABB standards, and includes requirements for volunteer donor blood and specific turnaround times for testing. Interested offerors must submit their proposals electronically by December 12, 2025, and direct any questions to Senior Contracting Officer Joshua I. Imdacha at joshua.imdacha@va.gov.
    6515--ON-X Consignment
    Buyer not available
    The Department of Veterans Affairs, Network Contract Office 17, is seeking to procure ON-X Heart Valves on a consignment basis for the North Texas VA Medical Center's Invasive Cardiology department. The contract will cover a base period of one year, with four optional renewal years, allowing the VA to pay only for the items used while the contractor maintains the inventory and provides necessary technical support and training. These heart valves are critical due to their unique clinical benefits, including a lower INR requirement that reduces the risk of bleeding for patients. Interested contractors must submit capability statements and be registered in SAM, with the anticipated award date around January 24, 2026, and the contract potentially expiring in January 2030 if all options are exercised. For further inquiries, contact Tammy L. Wilson at Tammy.wilson5@va.gov or 254-661-5372.